Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

NCT02227849 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Canagliflozin (TA-7284)
DRUG: GLP-1 analogue

Sponsor

Tanabe Pharma Corporation